Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Parenteral Drugs (India) Limited is a healthcare company. The Company is engaged in the manufacturing of allopathic pharmaceutical preparations.
Customise key metrics, see detailed forecasts, download stock data and more
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has almost stayed constant
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: 1st COC meetingThis is to inform you that the 1st Meeting of Committee of Creditors of Parenteral Drugs (India) Limited Under CIRP will be held on 13/03/2023 at 4:30 PM through video conference / other audio-visual method. | Download
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: 1st COC meetingThis is to inform you that the 1st Meeting of Committee of Creditors of Parenteral Drugs (India) Limited Under CIRP will be held on 13/03/2023 at 4:30 PM through video conference / other audio-visual method. | Download
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: Formation of COCThis is to inform you that, the Committee of Creditors of Parenteral Drugs (India) Limitedunder CIRP has been formed as on 03/03/2023, and same has been informed to Hon ble NCLT. | Download
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: Formation of COCThis is to inform you that, the Committee of Creditors of Parenteral Drugs (India) Limitedunder CIRP has been formed as on 03/03/2023, and same has been informed to Hon ble NCLT. | Download
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: List of CreditorsThis is to inform you that, the list of Creditors of Parenteral Drugs (India) Limited Under CIRP has been prepared on 03/03/2023 and uploaded in IBBI Website on 04/03/2023 and the same has been informed to Hon ble NCLT. | Download
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: List of CreditorsThis is to inform you that, the list of Creditors of Parenteral Drugs (India) Limited Under CIRP has been prepared on 03/03/2023 and uploaded in IBBI Website on 04/03/2023 and the same has been informed to Hon ble NCLT. | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant